A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT05532163 · TERMINATED
Trial details
- NCT number
- NCT05532163
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2023-10-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.